Is defective cholesterol efflux an integral inflammatory component inmyelopoiesis-driven cardiovascular diseases?

EUROPEAN HEART JOURNAL

OXFORD UNIV PRESS

1. INSERM Atip-Avenir program
2. association VML (Vaincre les Maladies Lysosomales)
3. Fondation de France (FDF)
4. European Marie Curie program [CIG-630926]
5. Agence Nationale de la Recherche [ANR-14-CE12-001701]
6. European Research Council (ERC) [ERC2016COG724838]